SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-18
👔
MapLight Therapeutics, Inc.
@MPLT_InsiderForm 4 Filing: Kroeger Christopher A. Sells $5.4M of $MPLT
INSIDER SALE
⚡ MATERIALITY: 8/10
corporate issuer
MapLight Therapeutics, Inc.
Ticker: $MPLT
Transaction Value
$5.4M
Price/Share: $36.87
transaction date
2026-07-15
Shares: 147,639
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Kroeger Christopher A., holds the title of Chief Executive Officer at MapLight Therapeutics, Inc..
On 2026-07-15, the insider transacted 147,639 shares.The shares were transacted at a weighted average price of $36.87 per share, resulting in a total market-relevant value of $5.4M.
Executive Summary Summary
Kroeger Christopher A. (Chief Executive Officer) sold $5.4M of $MPLT
Post-Transaction Position: 1,332,406 shares
SEC Accession No: 0001658918-26-000014 (CIK: 1658918)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.